NPs Basic Information
|
Name |
xylaripyone G
|
| Molecular Formula | C14H18O7 | |
| IUPAC Name* |
methyl2-(4-acetyloxybutyl)-4-methoxy-6-oxopyran-3-carboxylate
|
|
| SMILES |
COC(=O)c1c(OC)cc(=O)oc1CCCCOC(C)=O
|
|
| InChI |
InChI=1S/C14H18O7/c1-9(15)20-7-5-4-6-10-13(14(17)19-3)11(18-2)8-12(16)21-10/h8H,4-7H2,1-3H3
|
|
| InChIKey |
VPGXHQUGGCJCLQ-UHFFFAOYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 298.29 | ALogp: | 1.3 |
| HBD: | 0 | HBA: | 7 |
| Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 92.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 21 | QED Weighted: | 0.56 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.637 | MDCK Permeability: | 0.00008200 |
| Pgp-inhibitor: | 0.025 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.124 |
| 30% Bioavailability (F30%): | 0.977 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.93 | Plasma Protein Binding (PPB): | 43.68% |
| Volume Distribution (VD): | 0.627 | Fu: | 57.65% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.952 | CYP1A2-substrate: | 0.895 |
| CYP2C19-inhibitor: | 0.779 | CYP2C19-substrate: | 0.143 |
| CYP2C9-inhibitor: | 0.375 | CYP2C9-substrate: | 0.745 |
| CYP2D6-inhibitor: | 0.072 | CYP2D6-substrate: | 0.352 |
| CYP3A4-inhibitor: | 0.163 | CYP3A4-substrate: | 0.213 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 7.696 | Half-life (T1/2): | 0.826 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.643 |
| Drug-inuced Liver Injury (DILI): | 0.88 | AMES Toxicity: | 0.034 |
| Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.045 |
| Skin Sensitization: | 0.197 | Carcinogencity: | 0.031 |
| Eye Corrosion: | 0.005 | Eye Irritation: | 0.385 |
| Respiratory Toxicity: | 0.098 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004527 |  |
0.754 | D0VU8Q |  |
0.274 | ||
| ENC004524 |  |
0.734 | D08JIV |  |
0.252 | ||
| ENC004526 |  |
0.708 | D0I2WV |  |
0.252 | ||
| ENC004523 |  |
0.688 | D0Q6DX |  |
0.247 | ||
| ENC004525 |  |
0.662 | D02DKD |  |
0.245 | ||
| ENC004522 |  |
0.641 | D02LCR |  |
0.234 | ||
| ENC005635 |  |
0.580 | D09QEI |  |
0.233 | ||
| ENC005636 |  |
0.471 | D08VYV |  |
0.233 | ||
| ENC005954 |  |
0.406 | D06TQZ |  |
0.233 | ||
| ENC003263 |  |
0.406 | D0A1DH |  |
0.233 | ||